In our experience, treatment of Alzheimer’s disease and other causes of memory loss and dementia is best carried out in a partnership between the patient, his or her caregiver(s), and…
Memantine (Namenda) was approved by the FDA for the treatment of moderate to severe Alzheimer’s disease in 2003. In 2014 twice-daily Namenda was discontinued, once-daily Namenda extended-release (XR) was introduced,…
Quick Start Special Issues in Memory Loss, Alzheimer’s Disease, and Dementia Some Patients Do Not Want to Have Their Memory Evaluated • Help patients understand that the goal is to…
Patient EB is an 84-year-old woman who is living with her two nieces. She moved to the United States at age 22, never married, and worked in the fashion industry…
Many of our patients and their families ask us about whether they should take any one of the many supplements, herbs, vitamins, or over-the-counter medications they have seen in the…
Quick Start Non-Pharmacological Treatment of Memory Loss, Alzheimer’s Disease, and Dementia • Non-pharmacological treatments to help memory loss can improve function equal to or greater than medication. • External memory…
Quick Start Caring for and Educating the Caregiver • Alzheimer’s is a disease that affects the entire family. • Approximately 70% of patients with Alzheimer’s disease are cared for at…
When caregivers report behavioral and psychological symptoms we begin with an evaluation of the nature of the symptoms, level of distress they are causing the patient, and level of distress…
Quick Start Pharmacological Treatment of the Behavioral and Psychological Symptoms of Dementia • Pharmacological treatment of the behavioral and psychological symptoms of dementia should only be undertaken when one of…
Quick Start Life Adjustments for Memory Loss, Alzheimer’s Disease, and Dementia Issues in Mild Cognitive Impairment and Alzheimer’s Disease Dementia in the Very Mild and Mild Stages • Patients with…
